HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
HTG Molecular Diagnostics (HTGM) - Total debt
Total debt on the balance sheet as of March 2023 : $3.98 M
According to HTG Molecular Diagnostics 's latest financial reports the company's total debt is $3.98 M. A company’s total debt is the sum of all current and non-current debts.
HTG Molecular Diagnostics - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $4.83 M | -58.72% |
| 2021-12-31 | $11.7 M | -7.39% |
| 2020-12-31 | $12.64 M | 12.35% |
| 2019-12-31 | $11.25 M | 16.28% |
| 2018-12-31 | $9.67 M | 10.56% |
| 2017-12-31 | $8.75 M | -25.68% |
| 2016-12-31 | $11.77 M | 8.57% |
| 2015-12-31 | $10.84 M | -3.56% |
| 2014-12-31 | $11.24 M | 25398.44% |
| 2013-12-31 | $0.04 M | -78.5% |
| 2012-12-31 | $0.2 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.10 B | 2,564.45% | 🇺🇸 USA |
 Affimed
AFMD | $21.39 M | 437.44% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | $1.66 M | -58.15% | 🇺🇸 USA |